Merck, Glenmark headed to trial after judge scraps early dismissal bid in Zetia antitrust case

Thirteen years after the fact, a copycat accord with Glenmark Pharmaceuticals has come back to haunt Merck & Co. And now, the alleged pay-for-delay collaborators must face a jury trial.